Pbf Energy Inc.
—- Market cap
- —
- Debt
- +$2.15B
- Cash
- −$527.90M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $4.75B
Decision snapshot: PBF stock price at discount vs ACAD $76.77 current versus $1.14K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACAD's multiple
Implied fair value · at PBF's multiple
Needs PBF P/S.
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PBF FY 2025 (ended Dec 31, 2025) · ACAD FY 2025 (ended Dec 31, 2025).
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt · EV / Revenue 4.56x · EV / EBITDA 32.40x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PBF ENERGY INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ACADIA PHARMACEUTICALS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.40x
0.25x
Net debt / EBITDA
Leverage against operating earnings
4.41x
0.85x
Cash and equivalents
Liquid reserves on the balance sheet
$527.90M
$177.70M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
VALERO ENERGY CORP/TX
PBF vs VLO
Marathon Petroleum Corp
PBF vs MPC
Phillips 66
PBF vs PSX
Delek US Holdings, Inc.
PBF vs DK
SUPERNUS PHARMACEUTICALS, INC.
PBF vs SUPN
Sage Therapeutics, Inc.
PBF vs SAGE
Jazz Pharmaceuticals plc
PBF vs JAZZ
Alkermes plc.
PBF vs ALKS
Harmony Biosciences Holdings, Inc.
PBF vs HRMY
Krystal Biotech, Inc.
PBF vs KRYS
$2.15B
$306.51M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.